AVITA Medical (ASX:AVH) Insider Buys A$11,675.63 in Stock

AVITA Medical, Inc. (ASX:AVH) insider Robert McNamara purchased 10,022 shares of the business’s stock in a transaction dated Thursday, January 22nd. The shares were purchased at an average price of A$1.17 per share, for a total transaction of A$11,675.63.

AVITA Medical Price Performance

The company has a current ratio of 8.18, a quick ratio of 9.32 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $226.55 million, a P/E ratio of -5.55 and a beta of 1.54.

About AVITA Medical

AVITA Medical, Inc, together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc AVITA Medical, Inc was incorporated in 2020 and is headquartered in Valencia, California.